T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.07% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.39% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWN
1326
DELISTED
Southwestern Energy Company
SWN
| $2.77M | ﹤0.01% |
453,310
-12,076
| -3% | -$83.5K |
|
1327
Jack in the Box
JACK
$358M
| $2.77M | ﹤0.01% |
37,447
+12,843
| +52% | +$973K |
|
|
AVNS
1328
DELISTED
Avanos Medical
AVNS
| $2.77M | ﹤0.01% |
127,057
-9,657
| -7% | -$252K |
|
1329
News Corp Class B
NWS
$17.7B
| $2.77M | ﹤0.01% |
179,328
+28,611
| +19% | +$488K |
|
1330
Chord Energy
CHRD
$7.35B
| $2.75M | ﹤0.01% |
20,128
+14,151
| +237% | +$1.81M |
|
1331
Coherent
COHR
$64B
| $2.75M | ﹤0.01% |
78,860
+35,591
| +82% | +$1.7M |
|
1332
nVent Electric
NVT
$27.5B
| $2.72M | ﹤0.01% |
86,114
-1,934
| -2% | -$64.6K |
|
1333
Americold
COLD
$4.17B
| $2.71M | ﹤0.01% |
110,308
+10,140
| +10% | +$306K |
|
1334
Rapid Micro Biosystems
RPID
$85.3M
| $2.71M | ﹤0.01% |
837,855
-2,589,299
| -76% | -$10M |
|
1335
Prosperity Bancshares
PB
$8.95B
| $2.7M | ﹤0.01% |
40,468
-7,145
| -15% | -$510K |
|
1336
DT Midstream
DTM
$13.9B
| $2.7M | ﹤0.01% |
51,962
-4,885
| -9% | -$264K |
|
1337
Polaris
PII
$3.9B
| $2.69M | ﹤0.01% |
28,129
+1,151
| +4% | +$129K |
|
1338
Amdocs
DOX
$6.08B
| $2.69M | ﹤0.01% |
33,845
+8,265
| +32% | +$700K |
|
1339
Olin
OLN
$2.13B
| $2.69M | ﹤0.01% |
62,626
+20,341
| +48% | +$1.03M |
|
1340
Pricesmart
PSMT
$5.49B
| $2.66M | ﹤0.01% |
46,184
+1,024
| +2% | +$66.3K |
|
1341
Tenet Healthcare
THC
$21.5B
| $2.64M | ﹤0.01% |
51,187
+432
| +0.9% | +$25.6K |
|
1342
STAG Industrial
STAG
$7.12B
| $2.64M | ﹤0.01% |
92,850
+5,956
| +7% | +$188K |
|
1343
EPR Properties
EPR
$4.7B
| $2.64M | ﹤0.01% |
73,555
+6,434
| +10% | +$304K |
|
|
CHNG
1344
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $2.63M | ﹤0.01% |
95,833
+20,848
| +28% | +$517K |
|
1345
Ingredion
INGR
$6.54B
| $2.63M | ﹤0.01% |
32,688
-4,972
| -13% | -$436K |
|
1346
Avis
CAR
$4.93B
| $2.63M | ﹤0.01% |
17,715
-1,797
| -9% | -$295K |
|
1347
Starwood Property Trust
STWD
$6.09B
| $2.63M | ﹤0.01% |
144,333
+28,612
| +25% | +$648K |
|
1348
Arrow Electronics
ARW
$10.6B
| $2.63M | ﹤0.01% |
28,493
+5,097
| +22% | +$556K |
|
1349
Zillow
Z
$8.08B
| $2.63M | ﹤0.01% |
91,713
+547
| +0.6% | +$19K |
|
1350
United Bankshares
UBSI
$6.66B
| $2.61M | ﹤0.01% |
73,075
+9,058
| +14% | +$338K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.